Over the past decades, research has increasingly shifted toward understanding the broader physiological roles of glucagon, particularly its involvement—together with pancreatic α-cells—in the pathophysiology of type 2 diabetes mellitus (T2DM) and obesity [2]. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.